Verici Dx Plc (VRCI) ORD GBP0.001
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
3.38p
3.48p
12.50p
£8.19 million
3.38p
3.32p
2.88p
n/a
0.00p (0.00%) Previous:
0.00p
52,926
n/a
20,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2023 | 31/12/2022 |
|---|---|---|
| Revenue (£m) | 1.01 | n/a |
| Profit before tax (£m) | (8.73) | (11.41) |
| Adjusted EPS (p): | (5.10) | (6.90) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Verici Dx announces delay to Medicare determination for Tutivia test
11 October 2024 11:50
-
Verici Dx reaches Thermo Fisher collaboration milestone
1 July 2024 13:34
-
Verici Dx completes analytical validation on two assays
15 February 2022 14:28
-
Update on Local Coverage Determination and Trading
11 October 2024 07:00
-
Launch of PTRA Assay using Verici Dx's technology
31 July 2024 07:00
-
Half-year Report
15 July 2024 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.